The global allergy vaccine market size was worth around USD 1.64 billion in 2024 and is predicted to grow to around USD 4.50 billion by 2035 with a compound annual growth rate (CAGR) of 9.61% from 2025 to 2035. The growing prevalence of allergic diseases and rising government initiatives are driving the allergy vaccine market worldwide.